Hapvida is one of Brazil's largest private health-plan operators, built on a simple idea: own the clinics and hospitals, not just the insurance. That model made it a market favourite for years, but the past three have tested it hard. Full nameHapvida Participações e Investimentos S.A. Tickers / exchangeHAPV3 / B3 (São Paulo) HeadquartersFortaleza, Ceará, Brazil SectorHealthcare (health and dental plans) EmployeesNot disclosed in available sources Market valueR$3.71 billion (US$747 million) Yearly sales (TTM)R$31.86 billion (US$6.42 billion) Net profit (TTM)−R$141.7 million (US$−28.6 million) Net margin−0.55% (our calculation) Return on equity−0.36% …
Company Intelligence — Institutional Access
This dossier is part of our Company Intelligence database.
Full profiles, exchange dossiers and the regional intelligence briefs are available to institutional subscribers. Professional from US$490/year, Corporate US$1,450, Institutional US$3,900.
See institutional access →Already a subscriber? Log in.
Part of LatAm Company Intelligence
This company profile belongs to The Rio Times' research on every listed company and exchange in Latin America and the Caribbean. Browse the full intelligence hub →
Latest coverage
Brazil’s Hapvida Faces More Stock Pain, Analysts Warn
Foreign Investors Return to B3 as Squadra Flags Hapvida Mistake
Brazil Blocks Health Insurer Hapvida From Repricing 947,000 Plans
Hapvida’s Adjusted Q2 Profit All but Vanishes as Medical Costs Climb
Not ready to buy? Try Company Intelligence free for 14 days →
Editorial responsibility: Matthias Camenzind, Editor-in-Chief · Editorial standards · Report an error
Read More from The Rio Times
The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →